South & Central America Autoinjectors Market Size and Forecast (2021

Description

List of Tables

The South and Central America Autoinjectors Market is projected to reach US$ 245.5 Million by 2034, increasing from US$ 95.7 Million in 2025. The market is expected to register a CAGR of 11.3% during the forecast period from 2026 to 2034.

Executive Summary and South and Central America Autoinjectors Market Analysis:

The South & Central America (SCAM) autoinjectors market is witnessing steady growth, supported by the region's substantial diabetes burden, increasing awareness of self-administration technologies, and expanding use of biologic medicines requiring convenient injectable delivery systems. According to the International Diabetes Federation's Diabetes Atlas 11th Edition (2025), approximately 10.1% of adults in SCAM had diabetes in 2024, representing more than 35 million adults aged 20-79. Around 30% of affected individuals were estimated to remain undiagnosed, highlighting the considerable unmet need for effective disease management and accessible treatment options.

Insulin and other injectable therapies remain essential for many patients managing chronic conditions, creating sustained demand for convenient delivery technologies such as prefilled pens and autoinjectors. At the same time, increasing awareness of allergic and autoimmune disorders is contributing to demand for specialized autoinjectors, including epinephrine devices used during severe allergic reactions.

Although access to epinephrine autoinjectors differs considerably across Latin American countries, improvements in importation, distribution networks, and healthcare awareness are gradually increasing availability. Manufacturers are also introducing devices with ergonomic designs, simplified administration mechanisms, connectivity capabilities, and enhanced safety features, broadening the range of applications in both chronic and emergency care.

Government programs focused on chronic disease management and patient education are further encouraging self-care and home-based treatment. Together, the growing prevalence of diabetes, expanding biologic therapies, increased awareness of emergency self-administration, and ongoing innovation in drug-delivery technologies are creating favorable conditions for continued autoinjector market development across South and Central America.

Strategic Insights

South and Central America Autoinjectors Market Segmentation Analysis:

By Type, the South and Central America Autoinjectors Market is segmented into Disposable Prefilled Syringes and Reusable Prefilled Syringes. The Disposable Prefilled Syringes segment dominated the market in 2025.
By Application, the South and Central America Autoinjectors Market is categorized into Cancer, Diabetes, Autoimmune Disease, Infectious Diseases, and Others. The Others segment held the largest share in 2025.
By Distribution Channel, the South and Central America Autoinjectors Market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Channel. The Hospital Pharmacy segment accounted for the dominant share in 2025.

Market Report Scope

South and Central America Autoinjectors Market Outlook

Government-supported procurement and emergency preparedness programs represent an additional avenue for autoinjector market expansion beyond regular clinical applications. Countries such as Brazil, Argentina, and Chile are strengthening emergency response capabilities through strategic medical reserves, responder training, and improved access to essential medicines and medical equipment.

These preparedness initiatives can create opportunities for rapid drug-delivery technologies, including autoinjectors, particularly in situations requiring immediate treatment. Emergency systems designed to address mass-casualty incidents, chemical exposures, severe allergic reactions, and other time-sensitive medical events can benefit from portable delivery devices that simplify medication administration.

The incorporation of suitable emergency countermeasures into national or institutional reserves can also generate recurring procurement requirements. At the same time, greater availability of these devices can improve awareness among healthcare professionals, emergency responders, and the wider population regarding their potential applications.

In Brazil, Argentina, and Chile, ministries of health, emergency management organizations, and private healthcare companies are contributing to preparedness initiatives involving emergency medicine supplies and response infrastructure. Efforts to improve disaster readiness, strengthen medicine availability, and increase access to medical technologies demonstrate the role of public policy in supporting autoinjector adoption.

As governments across the region continue to emphasize rapid and decentralized treatment delivery, integrating autoinjectors into emergency preparedness frameworks could complement their growing use in chronic disease management. This combination of routine and emergency applications provides manufacturers with opportunities to expand their presence across the regional market.

South and Central America Autoinjectors Market Country Insights

By country, the South and Central America Autoinjectors Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest market share in 2025.

Brazil is the leading autoinjector market in the region, supported by its large population and considerable prevalence of diabetes requiring injectable therapies. According to the IDF Diabetes Atlas 11th Edition (2025), approximately 16.6 million Brazilian adults aged 20-79 were living with diabetes in 2024, representing around 10.6% of the country's adult population. This significant patient base creates sustained demand for insulin delivery technologies, including autoinjectors and prefilled injection systems.

Brazil's public healthcare system, Sistema Unico de Saude (SUS), has established programs addressing chronic disease management and patient education. Increasing emphasis on self-management and treatment outside traditional clinical settings can support wider use of convenient injection technologies.

Technological advancements are also influencing the Brazilian market. Ergonomically designed devices, simplified injection mechanisms, and safety-focused autoinjector platforms are becoming increasingly relevant to patients and healthcare professionals seeking more comfortable and reliable administration options. These improvements can contribute to greater adherence and confidence among individuals receiving long-term injectable treatments.

The increasing use of biologics for autoimmune conditions and greater awareness of severe allergies provide additional opportunities. While access to epinephrine autoinjectors remains uneven across different parts of Brazil, rising recognition of anaphylaxis and the importance of rapid self-administration is gradually encouraging greater availability, particularly in urban areas and healthcare settings.

Brazil's substantial disease burden, developing healthcare infrastructure, expanding awareness of self-care, and growing adoption of advanced drug-delivery technologies are expected to support its position as the primary autoinjector market in South and Central America.

South and Central America Autoinjectors Market Company Profiles

Some of the key players operating in the market include Phillips-Medisize, Gerresheimer AG, West Pharmaceutical Services Inc, Ypsomed Holding AG, Stevanato Group SpA, Becton Dickinson and Co, Owen Mumford Ltd, Haselmeier GmbH, Nemera, and SHL Medical.

These companies are pursuing strategies such as geographic expansion, product innovation, strategic partnerships, manufacturing investments, and mergers and acquisitions. Through these initiatives, manufacturers are seeking to develop more user-friendly and technologically advanced drug-delivery systems, strengthen distribution capabilities, expand regional operations, and increase their market share in the South and Central America autoinjectors market.

Product Code: TIPRE00043956

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Autoinjectors Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. South and Central America Autoinjectors Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Autoinjectors Market - South and Central America Analysis

5.1 South and Central America Autoinjectors Market Revenue (US$ Million), 2021 - 2034
5.2 South and Central America Autoinjectors Market Revenue Forecast and Analysis

6. South and Central America Autoinjectors Market Revenue Analysis - by Type

6.1 South and Central America Autoinjectors Market Forecast and Analysis by Type
- 6.1.1 Disposable Prefilled Syringes
  - 6.1.1.1 Overview
  - 6.1.1.2 Disposable Prefilled Syringes: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.2 Reusable Prefilled Syringes
  - 6.1.2.1 Overview
  - 6.1.2.2 Reusable Prefilled Syringes: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

7. South and Central America Autoinjectors Market Revenue Analysis - by Applications

7.1 South and Central America Autoinjectors Market Forecast and Analysis by Applications
- 7.1.1 Cancer
  - 7.1.1.1 Overview
  - 7.1.1.2 Cancer: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.2 Diabetes
  - 7.1.2.1 Overview
  - 7.1.2.2 Diabetes: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.3 Autoimmune Disease
  - 7.1.3.1 Overview
  - 7.1.3.2 Autoimmune Disease: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.4 Infectious diseases
  - 7.1.4.1 Overview
  - 7.1.4.2 Infectious diseases: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.5 Others
  - 7.1.5.1 Overview
  - 7.1.5.2 Others: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

8. South and Central America Autoinjectors Market Revenue Analysis - by Distribution Channel

8.1 South and Central America Autoinjectors Market Forecast and Analysis by Distribution Channel
- 8.1.1 Hospital Pharmacy
  - 8.1.1.1 Overview
  - 8.1.1.2 Hospital Pharmacy: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 8.1.2 Retail Pharmacy
  - 8.1.2.1 Overview
  - 8.1.2.2 Retail Pharmacy: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 8.1.3 Online Channel
  - 8.1.3.1 Overview
  - 8.1.3.2 Online Channel: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

9. South and Central America Autoinjectors Market - Country Analysis

9.1 South and Central America
- 9.1.1 South and Central America Autoinjectors Market Forecast and Analysis - by Country
  - 9.1.1.1 Brazil Market
    - 9.1.1.1.1 Brazil: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.1.2 Brazil: South and Central America Autoinjectors Market - By Segmentation
      - 9.1.1.1.2.1 Type
      - 9.1.1.1.2.2 Applications
      - 9.1.1.1.2.3 Distribution Channel
  - 9.1.1.2 Argentina Market
    - 9.1.1.2.1 Argentina: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.2.2 Argentina: South and Central America Autoinjectors Market - By Segmentation
      - 9.1.1.2.2.1 Type
      - 9.1.1.2.2.2 Applications
      - 9.1.1.2.2.3 Distribution Channel
  - 9.1.1.3 Rest of South and Central America Market
    - 9.1.1.3.1 Rest of South and Central America: South and Central America Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.3.2 Rest of South and Central America: South and Central America Autoinjectors Market - By Segmentation
      - 9.1.1.3.2.1 Type
      - 9.1.1.3.2.2 Applications
      - 9.1.1.3.2.3 Distribution Channel

10 Autoinjectors Market Industry Landscape

11 - Key Company Profiles

11.1 Phillips-Medisize
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Gerresheimer AG
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 West Pharmaceutical Services Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Ypsomed Holding AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Stevanato Group SpA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Becton Dickinson and Co
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Owen Mumford Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Haselmeier GmbH
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Nemera
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 SHL Medical
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 Glossary
12.2 Research Methodology and Approach
- 12.2.1 Secondary Research
- 12.2.2 Primary Research
- 12.2.3 Market Estimation Approach
  - 12.2.3.1 Supply Side Analysis
  - 12.2.3.2 Demand Side Analysis
- 12.2.4 Research Assumptions and Limitations
- 12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud